Hemant Kade, MD
Internal Medicine · Port Washington, NYNPI 1841539541
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,800 of the $11,340 with a category attached, or 68.8%. AbbVie accounts for 83.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $4,713 and has fallen 97.4% since, to $122 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $51.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Insmed, Inc.$377
- Amgen$331
- Gilead$286
- Paratek Pharmaceuticals, Inc.$221
- Melinta Therapeutics, LLC$178
- plus $527 from 12 others
What the payments were for
- Consulting fees$2002%
- Speaking & faculty fees$7,80069%
- Food & beverage$3,30329%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $9,419 |
| Insmed, Inc. | 29 | $377 |
| Amgen | 23 | $331 |
| Gilead | 9 | $286 |
| Paratek Pharmaceuticals, Inc. | 11 | $221 |
| Melinta Therapeutics, LLC | 11 | $178 |
| Viiv Healthcare Company | 6 | $113 |
| Merck | 5 | $77 |
| Grifols USA, LLC | 4 | $72 |
| Smith+Nephew | 4 | $66 |
| GRT US Holding, Inc. | 2 | $56 |
| Osiris Therapeutics Inc. | 2 | $45 |
| Theratechnologies Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $13 |
| Cashflow Solutions, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,340 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 15 | $2,394 |
| Cefdinir | 19 | $979 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $128 |
| Doxycycline Hyclate | 18 | $119 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Port Washington
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.